Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD and Food Effect Study of TBA-354
NCT02288481Phase 1Completed
- Sponsor
- TB Alliance
- Start
- Jan 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of TBA-354 in Tuberculosis (TB) (12 cohorts), sponsored by TB Alliance. Primary endpoint: Treatment Emergent Adverse Events at Day 14. Started Jan 2015; status: completed.
02
Drugs
TBA-354
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02288481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02288481.